🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 9 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/08/2016 5,97 6,09 5,79 5,86 -1,68% 5,06% 581.000
29/07/2016 6,00 6,02 5,89 5,96 -0,33% 2,18% 271.800
28/07/2016 6,02 6,12 5,90 5,98 -0,50% 3,65% 328.500
27/07/2016 5,76 6,04 5,76 6,01 +4,52% 4,86% 451.900
26/07/2016 5,64 5,83 5,54 5,75 +1,77% 5,05% 312.500
25/07/2016 5,65 5,69 5,50 5,65 +0,00% 3,27% 235.200
22/07/2016 5,58 5,75 5,52 5,65 +1,25% 4,12% 193.200
21/07/2016 5,74 5,85 5,48 5,58 -2,62% 6,45% 465.900
20/07/2016 5,61 5,80 5,61 5,73 +2,32% 3,39% 417.400
19/07/2016 5,88 5,94 5,58 5,60 -4,92% 6,12% 231.200
18/07/2016 5,80 5,90 5,74 5,89 +1,38% 2,76% 288.900
15/07/2016 5,58 5,87 5,54 5,81 +4,87% 5,91% 350.700
14/07/2016 5,65 5,71 5,52 5,54 -1,07% 3,42% 235.500
13/07/2016 5,86 5,92 5,60 5,60 -4,27% 5,46% 304.800
12/07/2016 5,81 5,98 5,78 5,85 +1,39% 3,51% 336.800
11/07/2016 5,76 5,88 5,68 5,77 +0,70% 3,47% 359.100
08/07/2016 5,60 5,74 5,56 5,73 +3,06% 3,21% 431.600
07/07/2016 5,49 5,60 5,40 5,56 +1,46% 3,64% 271.000
06/07/2016 5,36 5,62 5,34 5,48 +2,05% 5,22% 325.100
05/07/2016 5,43 5,49 5,33 5,37 -2,36% 3,04% 235.100
01/07/2016 5,29 5,58 5,29 5,50 +3,38% 5,48% 284.700
30/06/2016 5,39 5,50 5,28 5,32 -1,66% 4,08% 357.300
29/06/2016 5,37 5,46 5,25 5,41 +1,88% 3,91% 351.800
28/06/2016 5,11 5,40 5,11 5,31 +3,31% 5,68% 449.200
27/06/2016 5,42 5,45 5,08 5,14 -6,03% 6,83% 577.600
24/06/2016 5,58 5,78 5,28 5,47 -6,97% 8,96% 1.323.500
23/06/2016 5,73 5,89 5,67 5,88 +3,52% 3,84% 267.200
22/06/2016 5,65 5,80 5,52 5,68 +0,53% 4,96% 388.100
21/06/2016 5,91 5,94 5,56 5,65 -3,91% 6,43% 319.900
20/06/2016 5,82 5,99 5,76 5,88 +2,44% 3,95% 353.100